Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:04 AM
Ignite Modification Date:
2025-12-25 @ 3:04 AM
NCT ID:
NCT04180033
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of TC before age of 50 years
* Treatment of primary TC consisting at least: three cycles of platinum-based chemotherapy consisting of cisplatin
* At least 8 years after initial treatment
* At least 35 years of age and not older than 70 75 years
* Detection and potential treatment of advanced colorectal neoplasia is considered beneficial
Exclusion Criteria:
* A history of a proctocolectomy
* Colonoscopy surveillance for other indications (including hereditary CRC syndrome, familial CRC syndrome, inflammatory bowel disease, history of colorectal adenoma or CRC). Result of the prior colonoscopy will be put in the database and used for additional analyses
* Having received a colonoscopy in the past three years
* Currently receiving cytotoxic treatment or radiotherapy for malignant disease
* Coagulopathy (prothrombin time \<50% of control; partial tromboplastin time \>50 seconds) or anticoagulants (fenprocoumon, acenocoumarol, platelet aggregation inhibitors or new oral anticoagulants) that cannot be stopped or safely bridged if necessary
* Comorbidity leading to an impaired physical performance (World health organization (WHO) performance status 3-4) or mental retardation
* Limited Dutch language skills
* No informed consent
Healthy Volunteers:
True
Sex:
MALE
Minimum Age:
35 Years
Maximum Age:
75 Years
Study:
NCT04180033
Study Brief:
Protocol Section:
NCT04180033